Atlas Trials

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia

Clinical trial NCT01213836 · COMPLETED

Trial details

NCT number
NCT01213836
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2010-11-01
Primary completion
2011-08-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.